Abstract:

Key Populations are the major drivers of the HIV epidemic in most settings; thus, identifying positive KPs and their sexual partners becomes a strong strategy in the effort to achieve the first UNAID 95 goal. This study describes the level of acceptability and outcome of PNS among HIV-positive KPs using the various approaches for PNS. A descriptive study of all HIV positives KPs initiating ART in 7 One-Stop-Shop facilities that accepted PNS was conducted over 3 months. With the consent of patients who accepted PNS, their partners were reached using any of the PNS approaches. Partners who consented for HTS were tested, and positives partners were linked to ART services. Data were analyzed to describe the acceptability and outcome of PNS among KPs. Only 846/2,486 (34%) positive KPs accepted PNS. The 846 KPs elicited 941 partners, out of which 938 (99.6%) accepted HTS. 421/938 (45%) of the partners tested positive compared to PWIDF (15%), MSM (7%), FSW (4%) and PWIDM (4%). 129/421 (31%) of the positive partners were already known positives, with 61% already on ART. The commonest method of PNS accepted among KPs was the passive method (54%), followed by the contract method (22%), provider-initiated (19%), and dual method (5%). There was poor acceptance of PNS among KPs and, the HIV positivity rate was much higher among their partners than any of the KPs sub-groups. The passive approach was the most preferred method of PNS among KPs. This should be considered strongly as we scale up PNS in Nigeria.
Keywords: HIV/AIDS, Key Populations in Nigeria, Partner notification services, UNAIDS 95-95-95 targets.

References:

[1] World Health Organization Geneva (2016). Guidelines on HIV Self-Testing and Partner Notification: Supplement to Consolidated Guidelines on HIV Testing Services: World Health Organization; 2016 Dec. 3, Available from: https://www.ncbi.nlm.nih.gov/books/NBK401676/.

[2] The Global HIV epidemics (2019). Available at https://www.hiv.gov/hiv-basics/overview/data-and-trends/global-statistics.

[3] Averts (2020). HIV and AIDS in Nigeria. Available at https://www.avert.org/professionals/hiv-around-world/sub-saharan-africa/nigeria.

[4] Jennifer L. Weinberg and Carrie L. Kovarik MD. (2010). The WHO Clinical Staging System for HIV/AIDS, American Medical Association Journal Ethics, Volume 12, Number 3: 202-206.

[5] Averts (2020). HIV and AIDS in Nigeria. Available at https://www.avert.org/professionals/hiv-around-world/sub-saharan-africa/nigeria.

[6] Federal Ministry of Health Nigeria (2015). HIV Sero-prevalence among pregnant women in sentinel antenatal clinics by states: Available at http://www.sfhnigeria.org/wp-content/uploads/2018/05/National-Strategic-frame-work-Final-28th-May-2018.pdf.

[7] World Health Organization (2014); Consolidated guidelines on HIV prevention, diagnosis, treatment, and care for key populations. Available at http://apps.who.int/iris/bitstream/10665/128048/1/9789241507431_eng.pdf?ua=1&ua=1.

[8] Federal Ministry of Health Nigeria (2015). Integrated Biological and Behavioural Sentinel Survey (IBBSS 2014). Available at https://naca.gov.ng/wp-content/uploads/2016/11/Final-Nigeria-IBBSS-2014-report.pdf.

[9] Eluwa, G.I., Adebajo, S.B., Eluwa, T. et al. (2019). Rising HIV prevalence among men who have sex with men in Nigeria: a trend analysis. BMC Public Health 19, 1201 (2019). https://doi.org/10.1186/s12889-019-7540-4.

[10] UNAIDS (2012). UNAIDS report on the global AIDS epidemic. Available at http://www.unaids.org/sites/default/files/media_asset/20121120_UNAIDS_Global_Report_2012_with_annexes_en_1.pdf.

[11] UNAIDS press release (2015). Success in reaching 15 by 15 shows that we can end the AIDS epidemic available at http://www.unaids.org/en/resources/presscentre/pressreleaseandstatementarchive/2015/july/20150719_15x15_PR.

[12] Graham B, Daniel R, Gary WD, Jeanne E, Marina C, Natalie H, Jack W (2015). Investigating combination HIV prevention: isolated interventions or complex system JIAS open access. https://doi.org/10.7448/IAS.18.1.20499.

[13] UNAIDS (2015). Fast-tracking combination prevention towards reducing new HIV infection to fewer than 500,000 by 2020. http://www.unaids.org/sites/default/files/media_asset/20151019_JC2766_Fast-tracking_combination_prevention.pdf.

[14] UNAIDS (2017). Ending AIDS, progress towards the 90-90-90 targets. Available at http://www.unaids.org/sites/default/files/media_asset/Global_AIDS_update_2017_en.pdf.

[15] UNAIDS (2018). Accelerating towards 90-90-90. Available at http://www.unaids.org/en/resources/presscentre/featurestories/2018/july/90-90-90-targets-workshop.

[16] UNAIDS (2018). 90-90-90 treatment target. Available at http://www.unaids.org/en/90-90-90.

[17] UNAIDS (2020): Press Release. Available at https://www.unaids.org/en/resources/presscentre/pressreleaseandstatementarchive/2020/july/20200706_global-aids-report.

[18] UNAIDS (2015). Understanding fast-track, accelerating action to ends AIDS epidemic by 2030. https://www.unaids.org/sites/default/files/media_asset/201506_JC2743_Understanding_FastTrack_en.pdf.

[19] Sexual Partners, Partner Counseling and Referral Services (PCRS). Available at https://www.aids.gov/hiv-aids-basics/just-diagnosed-with-hiv-aids/talking-about-your-status/sexual-partners/.

[20] WHO; Call for case studies of HIV partner notification programmes. Available at http://www.who.int/hiv/mediacentre/news/hiv-partner-notification/en/.

[21] WHO; Call for case studies of HIV partner notification programmes, http://www.who.int/hiv/mediacentre/news/hiv-partner-notification/en/.

[22] Schneider G, Juday T, Wentworth C 3rd, Lanes S, Hebden T, Seekins D.(2013); Impact of health care payer type on HIV stage of illness at the time of initiation of antiretroviral therapy in the USA. AIDS Care. 2013;25(11):1470-6. DOI: 10.1080/09540121.2013.774316.

[23] Siegfried N, Uthman OA, Rutherford GW. (2017); Optimal time for initiation of antiretroviral therapy in asymptomatic, HIV-infected, treatment-naive adults. Cochrane Database Syst Rev. 2010 March 17;(3): CD008272. DOI: 10.1002/14651858.CD008272.pub2, https://www.ncbi.nlms.nih.gov/pubmed/20238364.

[24] Jennifer L. Weinberg and Carrie L. Kovarik, MD (2010); The WHO Clinical Staging System for HIV/AIDS, American Medical Association Journal Ethics, Volume 12, Number 3: 202-206.

[25] Federal Ministry of Health Abuja (2013). National HIV&AIDS and Reproductive Health Survey (NARHS plus 2012). Available at https://naca.gov.ng/narhs-plus-2012-final/.

[26] Felix A. Ogbo, Andrew Mogaji, Pascal Ogeleka, Kingsley E. Agho, John Idoko, Terver Zua Tule, and Andrew (2017) Assessment of provider-initiated HIV screening in Nigeria with sub-Saharan African comparison. BMC Health Serv Res. 2017; 17: 188. DOI: 10.1186/s12913-017-2132-4.

[27] Adaora Adeline Okechukwu, Eno Ekop, Chinwendu Daniel Ndukwe, Kudirat Eyinade Olateju (2016). Acceptance of provider-initiated testing and counseling for HIV infection by caregivers in a tertiary health institution in Abuja, Nigeria: a cross-sectional study. The Pan African Medical Journal. 2016;24:245. Doi:10.11604/pamj.2016.24.245.9057.

[28] Nigerian HIV/AIDS Indicator and Impact Survey (2018); Technical Report.

[29] Moses Katbi, Adeoye Adegboye, Adefisayo Adedoyin, Fadimatu Yunusa, Gbenga Kayode, Maryam Bello, Patrick Dakum (2018). Effect of clients Strategic Index Case Testing on community-based detection of HIV infections (STRICT study). International Journal of Infectious Diseases 74 (2018)
54–60.

DOI: https://doi.org/10.1016/j.ijid.2018.06.018.

[30] World Health Organization (2016): Guidelines on HIV Self-Testing and Partner Notification: Supplement to Consolidated Guidelines on HIV Testing Services. Accessed on October 2020 https://www.ncbi.nlm.nih.gov/books/NBK401684/.